VYNE (NASDAQ: VYNE) CEO stock withheld to cover RSU tax bill

Rhea-AI Filing Summary

VYNE Therapeutics President and CEO David Domzalski had 14,232 shares of Common Stock withheld on March 31, 2026 to cover tax obligations from vesting restricted stock units. This was a tax-withholding disposition at $0.5975 per share, and he continues to hold 401,976 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Domzalski David

Role PRESIDENT AND CEO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	14,232	$0.5975	$9K

Holdings After Transaction: Common Stock — 401,976 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares withheld for taxes: 14,232 shares Withholding price per share: $0.5975 per share Shares held after transaction: 401,976 shares +1 more

4 metrics

Shares withheld for taxes 14,232 shares Tax-withholding disposition on March 31, 2026

Withholding price per share $0.5975 per share Value used for tax-withholding shares

Shares held after transaction 401,976 shares Direct holdings following tax withholding

Tax-withholding shares 14,232 shares Classified as taxWithholdingShares in transaction summary

Key Terms

Common Stock, restricted stock units, tax withholding requirements, tax-withholding disposition

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

restricted stock units financial

"in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding requirements financial

"withheld by the Issuer to satisfy tax withholding requirements"

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Domzalski David

(Last) (First) (Middle)

C/O VYNE THERAPEUTICS INC.

P.O. BOX 125

(Street)

STEWARTSVILLE NEW JERSEY 08886

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VYNE Therapeutics Inc. [ VYNE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT AND CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		F(1)		14,232	D	$0.5975	401,976	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

	/s/ Mutya Harsch, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did VYNE (VYNE) CEO David Domzalski report in this Form 4?

David Domzalski reported a tax-withholding disposition of 14,232 VYNE Therapeutics common shares. The issuer withheld these shares to satisfy tax obligations from vesting restricted stock units, rather than through an open-market sale or discretionary trading decision.

How many VYNE shares were withheld for taxes and at what price?

A total of 14,232 VYNE Therapeutics common shares were withheld at $0.5975 per share. This withholding satisfied tax requirements tied to restricted stock unit vesting, and did not involve Domzalski selling shares into the open market.

How many VYNE shares does the CEO hold after this tax withholding?

After the tax-withholding transaction, David Domzalski directly holds 401,976 shares of VYNE Therapeutics common stock. This figure reflects his position following the 14,232-share withholding related to restricted stock unit vesting.

Was this VYNE CEO Form 4 transaction an open-market sale of shares?

No, this transaction was not an open-market sale. Shares were withheld by VYNE Therapeutics to satisfy tax withholding requirements triggered by vesting restricted stock units, a common non-market mechanism rather than a discretionary sale by the CEO.

What does a tax-withholding disposition mean for VYNE shareholders?

A tax-withholding disposition means the company retains shares to cover the insider’s tax obligations on equity awards. It is a routine, compensation-related event and generally provides less insight into the insider’s market view than a voluntary open-market purchase or sale.